Clinical Trial Update: A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) [Phase 1]

View source ↗

Summary

This update covers the completed Phase 1 study of the investigational drug JNJ-67856633 in participants with non-Hodgkin lymphoma and chronic lymphocytic leukem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Non-hodgkin Lymphoma

Drugs mentioned

• JNJ-67856633

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin | Phase 1 | Status: COMPLETED